Senior scientist Shahid Jameel says the partially successful HIV vaccine trial in Thailand has offered a direct opportunity to understand the correlates of protection in humans. The initial trial results, though modest, will surely energise HIV vaccine research towards a more complete analysis of the successful immune response
Research
|